CIT

City of Hope finds potential cure for type 1 diabetes

Friday, May 18, 2012 10:11 AM

City of Hope, a research, treatment and education center for cancer, diabetes and other life-threatening diseases based in Duarte, Calif., has developed a combination therapy to treat late-stage type 1 diabetes (T1D) that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study was published in the May 9, 2012, edition of Science Translational Medicine.

More... »

BioCity Scotland secures former MSD site

Wednesday, January 18, 2012 12:09 PM

Newly-formed BioCity Scotland, a centralized base for growing bioscience, pharameutical, med tech and health companies, will set up house in the former-MSD research facility at Newhouse, which it acquired Jan. 11.

More... »

Anavex names executive director

Wednesday, October 12, 2011 11:52 AM

Anavex Life Sciences has named Dr. George Tidmarsh executive director. 

More... »

Insufficient advisory board members due to conflict-of-interest rules

Wednesday, July 27, 2011 01:19 PM

Conflict-of-interest rules restricting scientists with financial ties to drug and device- makers from advising U.S. regulators may loosen next year, said FDA Commissioner Margaret Hamburg, according to Bloomberg News.

More... »

CiToxLAB names director of scientific projects

Wednesday, July 6, 2011 10:09 AM

CiToxLAB, a non-clinical CRO, named Paul C. Barrow director of scientific projects and client consulting.

More... »

Report of flat R&D pipeline: good news amid economic woes or sign of more turmoil ahead?

Tuesday, July 5, 2011 08:02 AM

The research and development pipeline has officially flattened out.

More... »

Oncology drug development investment remains strong

Thursday, June 2, 2011 12:39 PM

Investment in oncology drug development remains strong, as 133 companies initiated late-stage clinical trials from October 2009 to September 2010, a 21% increase, according to Citeline, a research company focusing on pharmaceutical clinical trials and intelligence.

More... »

CIT acquires assets of LAB Research

Wednesday, April 27, 2011 04:05 PM

Applied Biology Company (ABC), the holding company of France-based CRO CIT Safety & Health Research Laboratories (CIT), has purchased all of the assets of CRO LAB Research consisting of three facilities located in Canada, Denmark and Hungary.

More... »

CIT and Stemina partner for stem cell toxicology testing

Tuesday, March 1, 2011 01:00 PM

CIT Safety and Health Research Laboratories and Stemina Biomarker Discovery have formed a partnership.

More... »